Featured Research

from universities, journals, and other organizations

PTSD treatment cost-effective when patients given choice

Date:
May 28, 2014
Source:
University of Washington
Summary:
A cost-analysis of post-traumatic stress disorder treatments shows that letting patients choose their course of treatment – either psychotherapy or medication – is less expensive than assigning a treatment and provides a higher quality of life for patients. “This is one of the first studies to look at the cost of providing mental health care and comparing different treatments for PTSD,” said a co-author of the study. “It has tremendous implications for how large health care systems such as the U.S. Department of Veterans Affairs proceed with treating PTSD.”

A cost-analysis of post-traumatic stress disorder treatments shows that letting patients choose their course of treatment – either psychotherapy or medication – is less expensive than assigning a treatment and provides a higher quality of life for patients.

Related Articles


In a recent study, published in the Journal of Clinical Psychiatry, PTSD patients allowed to choose between therapies ended up costing about $1,622 less on average per patient per year compared with patients who were assigned treatment. Among patients not given a choice, treatment with prolonged exposure psychotherapy cost less on than sertraline.

“This is one of the first studies to look at the cost of providing mental health care and comparing different treatments for PTSD,” said Lori Zoellner, co-author of the study and director of the University of Washington’s Center for Anxiety and Traumatic Stress. “It has tremendous implications for how large health care systems such as the U.S. Department of Veterans Affairs proceed with treating PTSD.”

The National Institute of Mental Health funded the study, with additional funding from the American Association of Colleges of Pharmacy.

“In evaluating how well a treatment works, we seldom pay attention to the role of a patient’s preference, although it could be particularly important in mental health treatments,” Zoellner said. “Trauma survivors with PTSD often have strong opinions about wanting to talk about the trauma or not in therapy, some believing they really need to talk about it to heal and others really wanting to avoid talking about it. They may experience greater relief when they receive the treatment that they prefer.”

Since randomized clinical trials – the gold-standard in research – don’t accommodate patients’ preferences, Zoellner and her research team used a study design called a “doubly randomized preference trial” to investigate whether giving patients a choice affects their treatment outcomes.

“Most clinical studies try to answer which treatment works best but do not factor in how giving patients choices could affect their health,” said Quang Le, lead author and an assistant professor of pharmacy at Western University of Health Sciences in Pomona, Calif. “With this study design we could isolate the effects of this patient choice and see if it is cost-effective.”

The 200 participants – all diagnosed with PTSD and aged 18 to 65 years – were assigned to a group that was allowed to select their own treatment or a group that had their treatment chosen for them.

They were then given 10 weeks of treatment with either the drug sertraline or counseling called “prolonged exposure therapy.” Sertraline, prescribed under the names Zoloft and Lustral, is an antidepressant manufactured by Pfizer, Inc., which supplied the drug for use in the study.

When study participants were given a choice, their treatment cost each year an average of $6,156 compared with $7,778 for those assigned a treatment – a difference of approximately $1,622 per patient per year.

Among the patients not given a choice of treatment, counseling with prolonged exposure therapy cost on average slightly less than pharmacotherapy with sertraline – $7,030 versus $8,650 per patient per year.

“If it isn’t possible to allow patients to choose, prolonged exposure therapy rather than the medication is a cost-effective treatment option,” Zoellner said.

The costs in 2012 U.S. dollars included the therapy, outpatient services, hospitalization, emergency department visits, pharmacy services and nonmedical services, as well as indirect costs such as losses in worker productivity.


Story Source:

The above story is based on materials provided by University of Washington. The original article was written by Molly McElroy. Note: Materials may be edited for content and length.


Journal Reference:

  1. Quang A. Le, Jason N. Doctor, Lori A. Zoellner, Norah C. Feeny. Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial). The Journal of Clinical Psychiatry, 2014; 75 (03): 222 DOI: 10.4088/JCP.13m08719

Cite This Page:

University of Washington. "PTSD treatment cost-effective when patients given choice." ScienceDaily. ScienceDaily, 28 May 2014. <www.sciencedaily.com/releases/2014/05/140528132703.htm>.
University of Washington. (2014, May 28). PTSD treatment cost-effective when patients given choice. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2014/05/140528132703.htm
University of Washington. "PTSD treatment cost-effective when patients given choice." ScienceDaily. www.sciencedaily.com/releases/2014/05/140528132703.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins